There has been a great deal of interest in the therapeutic role of beta-adrenergic blockade in patients suffering from vasovagal syncope. The efficacy of beta-blockers in these patients may be due to blunting of elevated catecholamine levels that precede vasovagal syncope (1) . Notwithstanding the widespread use of beta-blockers in the past, some studies on chronic beta-blocker use have been less than encouraging and may suggest some benefit in older but not in younger patients, as mentioned in the recent article by Tan and Parry (2) . That being said, might there be a better way to predict the favorable use of beta-blocker therapy in patients suffering from vasovagal syncope? In one study of patients with confirmed vasovagal syncope, all patients with a negative tilt test response during esmolol infusion had a negative tilt test response with oral metoprolol. Of the remaining patients with a positive tilt test response during esmolol infusion, 90% continued to have a positive response with oral metoprolol (3). In another study, a negative test with esmolol infusion among 112 patients with vasovagal syncope was again found to be an independent predictor for prevention of symptoms with oral metoprolol during follow-up of 2.7 Ϯ 1.2 years (p Ͻ 0.0001) (4). Those authors concluded that "acute challenge with esmolol infusion appears to be an accurate predictor of response to chronic beta-blockers." A negative head-up tilt test during propanolol infusion was similarly found to predict favorable responses to oral beta-blocker therapy in other studies, including a prospective trial of 296 patients (5-7). Thus, data on the effectiveness of a beta-blocker challenge during the head-up tilt test in patients with vasovagal syncope may be very helpful in formulating a therapeutic strategy.
Reply
We thank Dr. Kapoor for his interest in our recent paper (1) . As mentioned by Dr. Kapoor, beta-blockers had indeed found widespread usage in the treatment of vasovagal syncope in the past. Earlier uncontrolled studies (2,3) and 1 small randomizedcontrolled study (4) had demonstrated encouraging results, fueling this practice. However, recent randomized controlled trials (5,6), as well as the only multicenter, randomized, placebo-controlled trial published to date (7) , have failed to demonstrate any beneficial effects with beta-blockers. There was a statistically nonsignificant trend to benefit in the subgroup of subjects Ն42 years of age, suggesting that further evaluation of the use of beta-blockers in older subjects may be warranted (8).
The studies cited by Dr. Kapoor were uncontrolled studies evaluating the role of intravenous beta-blockers in predicting treatment response to long-term oral beta-blocker therapy. Following the positive diagnosis of vasovagal syncope with a head-up tilt (HUT) test, a second HUT was performed to assess response to intravenous esmolol or propanolol (9 -11). However, there has been a reasonable body of evidence demonstrating that the reproducibility of a positive HUT is low (12-15). The role of HUT as an instrument to evaluate treatment benefit is therefore limited, and can only be used in this context if a comparison is made with placebo (16). 
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